valine and cladribine

valine has been researched along with cladribine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acker, T; Andrulis, M; Blume, C; Capper, D; Dietrich, S; Fröhling, S; Garvalov, BK; Glimm, H; Ho, AD; Hüllein, J; Hundemer, M; Jethwa, A; Lehners, N; Mandel, T; Meissner, J; Schulte, C; von Kalle, C; Zenz, T	1

Other Studies

1 other study(ies) available for valine and cladribine

Article	Year
Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-01, Volume: 31, Issue:19 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Drug Resistance, Neoplasm; Flow Cytometry; Glutamic Acid; Humans; Indoles; Induction Chemotherapy; Leukemia, Hairy Cell; Male; Middle Aged; Molecular Targeted Therapy; Point Mutation; Proto-Oncogene Proteins B-raf; Rituximab; Sulfonamides; Treatment Outcome; Valine; Vemurafenib	2013

Article

Year

Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-01, Volume: 31, Issue:19

Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Drug Resistance, Neoplasm; Flow Cytometry; Glutamic Acid; Humans; Indoles; Induction Chemotherapy; Leukemia, Hairy Cell; Male; Middle Aged; Molecular Targeted Therapy; Point Mutation; Proto-Oncogene Proteins B-raf; Rituximab; Sulfonamides; Treatment Outcome; Valine; Vemurafenib

2013